Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joong Goo Kwon is active.

Publication


Featured researches published by Joong Goo Kwon.


Alimentary Pharmacology & Therapeutics | 2012

Randomised clinical trial: comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients

H. G. Park; Min Kyu Jung; Jin Tae Jung; Joong Goo Kwon; Eun Young Kim; H. E. Seo; Jin Ho Lee; Chang Hun Yang; E. S. Kim; K. B. Cho; K. S. Park; Si-Hyung Lee; Kyeong Ok Kim; Seong Woo Jeon

Aliment Pharmacol Ther 2012; 35: 56–65


Surgical Endoscopy and Other Interventional Techniques | 2010

Clinical outcomes for perforations during endoscopic submucosal dissection in patients with gastric lesions.

Seong Woo Jeon; Min Kyu Jung; Sung Kook Kim; Kwang Bum Cho; Kyung Sik Park; Chang Keun Park; Joong Goo Kwon; Jin Tae Jung; Eun Young Kim; Tae Nyeun Kim; Byung Ik Jang; Chang Hun Yang

BackgroundThe endoscopic submucosal dissection (ESD) technique has been gaining popularity, with continued advances in this treatment approach. However, ESD still is associated with potential complications such as severe bleeding and perforation.MethodsThis study was performed to compare the clinical outcomes for macro- and microperforations with ESD procedures and to determine the short-term prognosis after ESD. A macroperforation was defined as a gross perforation that occurred during an ESD procedure, and a microperforation was defined by free air observed on simple radiography after the procedure. Immediate closure of macroperforations was performed using endoclips. From July 2003 through May 2008, 1,711 patients underwent ESD for gastric lesions such as dysplasia, early cancer, and subepithelial lesions.ResultsAmong 39 perforation cases (2.3%), macroperforations occurred for 26 patients (67%) and microperforations for 13 patients (33%). All the patients except one who underwent emergency surgery because of severe bleeding and perforation during ESD were managed successfully by intravenous antibiotics and no oral intake. The clinical prognosis and endoscopic characteristics of the patients with macroperforations did not differ from those of the patients with microperforations.ConclusionsPerforations associated with ESD could be managed safely and successfully by nonsurgical methods. The clinical prognoses for macro- and microperforations were favorable and comparable.


Gut and Liver | 2015

Clinical Outcomes of the Endoscopic Submucosal Dissection of Early Gastric Cancer Are Comparable between Absolute and New Expanded Criteria

Keun Young Shin; Seong Woo Jeon; Kwang Bum Cho; Kyung Sik Park; Eun Soo Kim; Chang Keun Park; Yun Jin Chung; Joong Goo Kwon; Jin Tae Jung; Eun Young Kim; Kyeong Ok Kim; Byung Ik Jang; Si Hyung Lee; Jeong Bae Park; Chang Hun Yang

Background/Aims Advances in endoscopic submucosal dissection (ESD) techniques have led to the development of expanded criteria for endoscopic resection of early gastric cancer (EGC). The aim of this study was to evaluate the short- and long-term outcomes for ESD using indication criteria. Methods A total of 1,105 patients underwent ESD for EGC at six medical centers. The patients were classified into the following two groups based on the lesion size, presence of ulceration and pathological review: an absolute criteria group (n=517) and an expanded criteria group (n=588). Results The curative resection rates (91.1% vs 91.3%, p=0.896) were similar in the absolute criteria group and the expanded criteria group. The en bloc resection rates (93.4% and 92.3%, respectively; p=0.488) and complete resection rates (98.3% and 97.4%, respectively; p=0.357) did not differ between the groups. The cumulative disease-free survival rates and the overall survival rates were similar between the groups (p=0.778 and p=0.654, respectively). Independent factors for the curative resection of EGC included tumor location (upper vs middle and lower, 2.632 [1.128–6.144] vs 3.497 [1.560–7.842], respectively) and en bloc resection rate 12.576 [7.442–21.250]. Conclusions The expanded criteria for ESD in cases of EGC is comparable with the widely accepted pre-existing criteria.


Journal of Gastroenterology and Hepatology | 2015

Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.

Jun Heo; Seong Woo Jeon; Jin Tae Jung; Joong Goo Kwon; Dong Wook Lee; Hyun Soo Kim; Chang Hun Yang; Jeong Bae Park; Kyung Sik Park; Kwang Bum Cho; Si Hyung Lee; Byung Ik Jang

This study aimed to validate the equivalence of first‐line concomitant and hybrid regimens for Helicobacter pylori infection in an era of increasing antibiotic resistance. The study also aimed to assess regimen compliance.


Digestive and Liver Disease | 2014

A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication

Jun Heo; Seong Woo Jeon; Jin Tae Jung; Joong Goo Kwon; Eun Young Kim; Dong Wook Lee; Hyang Eun Seo; Chang Yoon Ha; Hyun Jin Kim; Eun Soo Kim; Kyung Sik Park; Kwang Bum Cho; Si Hyung Lee; Byung Ik Jang

BACKGROUND As a result of increased resistance to antibiotics, Helicobacter pylori eradication rates using standard triple therapy have been declining. AIM To validate the efficacy and tolerability of a concomitant regimen as a first-line treatment for H. pylori infection. METHODS A total of 348 naïve H. pylori-infected patients from six hospitals in Korea were randomly assigned to concomitant therapy and standard triple therapy groups. The concomitant regimen consisted of 30 mg of lansoprazole, 1g of amoxicillin, 500 mg of clarithromycin, and 500 mg of metronidazole, twice daily for 10 days. The standard triple regimen consisted of 30 mg of lansoprazole, 1g of amoxicillin, and 500 mg of clarithromycin, twice daily for 10 days. RESULTS Concomitant and standard eradication rates were 78.7% (137/174) vs. 70.7% (123/174) by intention-to-treat (p=0.084) and 88.7% (133/150) vs. 78.4% (120/153) by per-protocol (p=0.016), respectively. The two groups were similar with regard to the incidence of adverse events. CONCLUSIONS Although 10-day concomitant therapy was validated as a suboptimal treatment option for the treatment of H. pylori infection, this regimen is expected to be a promising starting point in the development of an optimal treatment regimen for H. pylori infection.


Clinical Endoscopy | 2013

Late Complications and Stone Recurrence Rates after Bile Duct Stone Removal by Endoscopic Sphincterotomy and Large Balloon Dilation are Similar to Those after Endoscopic Sphincterotomy Alone

Ka Young Kim; Jimin Han; Ho Gak Kim; Byeong Suk Kim; Jin Tae Jung; Joong Goo Kwon; Eun Young Kim; Chang Hyeong Lee

Background/Aims Between endoscopic sphincterotomy (ES) alone and combined endoscopic sphincterotomy and large balloon dilation (ES-LBD) groups, efficacy and long-term complications, difference in biliary stone recurrence rate, and risk factors of stone recurrence were compared. Methods Medical records of 222 patients who underwent ERCP for biliary stone removal were retrospectively reviewed. Patients with dilated CBD ≥11 mm and follow-up longer than 6 months were included. Results There were 101 patients in ES-LBD group and 121 patients in ES group. Mean follow-up duration was 25.0 (6-48) months and 13.0 (6-43) months, respectively (p=0.001). There was no difference in number of ERCP sessions, brown pigment stones, angle between mid and distal common bile duct (CBD angle) <135°, and lithotripsy rate. Complete retrieval success rate was excellent in both groups (100% vs. 99%). Early complication rate of ES-LBD and ES alone group was 4 and 4.1%, respectively (p=1.000). One patient in ES-LBD group died from delayed bleeding. Late complication rate was 5.9 and 3.3%, respectively (p=1.000). Stone recurrence rate was 6.9% and 5.8%, respectively (p=0.984). The only Independent risk factor of stone recurrence was presence of periampullary diverticulum. Conclusions Late complication and stone recurrence rates were similar between ES-LBD and ES alone groups.


Journal of Neurogastroenterology and Motility | 2011

Alterations of Colonic Contractility in Long-term Diabetic Rat Model

Sun Joo Kim; Jae Hyung Park; Dae Kyu Song; Kyung Sik Park; Jeong Eun Lee; Eun Soo Kim; Kwang Bum Cho; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang; Joong Goo Kwon; Tae Wan Kim

Background/Aims Dysfunction of the gastrointestinal tract occurs in about 76% of patients who are diabetic for more than 10 years. Although diabetes-related dysfunctions of the stomach such as gastroparesis have been extensively studied over the recent years, studies about the mechanism underlying colonic symptoms in long-term diabetes models are rare. Therefore, the goal of our study was to clarify the nature of colonic dysfunction in a long-term diabetic rat model. Methods The characteristics of colonic smooth muscle were investigated in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes. These results were compared to those obtained from Long-Evans Tokushima Otsuka (LETO) control rats. Results Spontaneous contractility of the proximal colon was significantly decreased in the diabetic rats compared to the controls, while the spontaneous contractility of the distal colon was not. The number of interstitial cells of Cajal networks in the proximal colon was greatly decreased in diabetic rats compared to the controls. Contractility of the proximal colon in response to carbachol, an acetylcholine receptor agonist, was significantly weaker in the diabetic rats. In addition, the degree of relaxation in response to nitric oxide in the proximal colon of diabetic rats also appeared to be attenuated. Conclusions The results from our study suggest that the decrease of interstitial cells of Cajal network, cholinergic receptors, and neuronal nitric oxide synthase in the proximal colon plays important roles in diabetes-related dysfunction of colon.


Neurogastroenterology and Motility | 2015

Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial

Chang Hwan Choi; Joong Goo Kwon; Sung Kook Kim; Seung-Jae Myung; Kyung Sik Park; Chong-Il Sohn; Poong-Lyul Rhee; Kang-Hong Lee; Oh Young Lee; Hye-Kyung Jung; Sam Ryong Jee; Yoon Tae Jeen; Myung-Gyu Choi; Suck Chei Choi; Kyu-Chan Huh; Hae-Jeong Park

Probiotics can be beneficial in irritable bowel syndrome (IBS). Mosapride citrate, a selective 5‐HT4 receptor agonist, stimulates gastrointestinal motility. We investigated the efficacy of combination therapy with probiotics and mosapride for non‐diarrheal‐type IBS.


Neurogastroenterology and Motility | 2012

Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.

W. Sohn; Oh-Young Lee; Joong Goo Kwon; Kyung Sik Park; Y. J. Lim; T. H. Kim; S. W. Jung; J. I. Kim

Background  Tricyclic antidepressants have good efficacy in irritable bowel syndrome with diarrhea (IBS‐D), but their clinical use is limited by considerations of tolerability. Tianeptine, another antidepressant, acts as a selective serotonin reuptake enhancer. We compared tianeptine with amitriptyline for the treatment of patients with IBS‐D.


Journal of Neurogastroenterology and Motility | 2015

Alterations of Colonic Contractility in an Interleukin-10 Knockout Mouse Model of Inflammatory Bowel Disease

Jae Hyung Park; Joong Goo Kwon; Sun Joo Kim; Dae Kyu Song; Seok Guen Lee; Eun Soo Kim; Kwang Bum Cho; Byung Ik Jang; Dae Hwan Kim; Jeong-Im Sin; Tae Wan Kim; In Hwan Song; Kyung Sik Park

Background/Aims Inflammatory bowel disease is commonly accompanied by colonic dysmotility and causes changes in intestinal smooth muscle contractility. In this study, colonic smooth muscle contractility in a chronic inflammatory condition was investigated using smooth muscle tissues prepared from interleukin-10 knockout (IL-10−/−) mice. Methods Prepared smooth muscle sections were placed in an organ bath system. Cholinergic and nitrergic neuronal responses were observed using carbachol and electrical field stimulation with L-NG-nitroarginine methyl ester (L-NAME). The expression of interstitial cells of Cajal (ICC) networks, muscarinic receptors, neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) was observed via immunofluorescent staining. Results The spontaneous contractility and expression of ICC networks in the proximal and distal colon was significantly decreased in IL-10−/− mice compared to IL-10+/+ mice. The contractility in response to carbachol was significantly decreased in the proximal colon of IL-10−/− mice compared to IL-10+/+ mice, but no significant difference was found in the distal colon. In addition, the expression of muscarinic receptor type 2 was reduced in the proximal colon of IL-10−/− mice. The nictric oxide-mediated relaxation after electrical field stimulation was significantly decreased in the proximal and distal colon of IL-10−/− mice. In inflamed colon, the expression of nNOS decreased, whereas the expression of iNOS increased. Conclusions These results suggest that damage to the ICC network and NOS system in the proximal and distal colon, as well as damage to the smooth muscle cholinergic receptor in the proximal colon may play an important role in the dysmotility of the inflamed colon.

Collaboration


Dive into the Joong Goo Kwon's collaboration.

Top Co-Authors

Avatar

Jin Tae Jung

Catholic University of Daegu

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ho Gak Kim

Catholic University of Daegu

View shared research outputs
Top Co-Authors

Avatar

Seong Woo Jeon

Kyungpook National University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jimin Han

Catholic University of Daegu

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge